Healthcare Professionals

Committed to helping you enhance your practice and the experience of your patients through connected devices and digitalised data sharing.

Healthcare Professionals
  • Primary Care

    Supporting every aspect of your clinical practice, including physical exam, diagnostic cardiology, vitals monitoring and vision screening

  • Hospital Care

    Advancing products and technologies designed to speed patient recovery and streamline clinical workflows

  • Surgical Care

    Delivering innovations that enable reduced operating times, faster patient recovery and improved outcomes

  • Nutritional Care

    Personalizing nutritional care designed to improve patients’ health in the hospital, the ICU and at home

  • Respiratory Care

    Helping your patients with respiratory therapies designed to simplify delivery and improve mobility

  • Our Products & Services

    Our portfolio of acute, nutritional, hospital and surgical care products helps advance healthcare around the world.

Perspectives

For nearly a century, we have worked at the intersection of saving and sustaining lives.

Perspectives

Our Story

Our 90-year heritage gives us distinct perspective on the needs of patients and caregivers. We lead today by putting those insights to work to deliver new, better healthcare solutions and access to care in the communities where we live and work.

Our Story
  • Our Leadership

    Our forward-looking leadership team is a driving force in ensuring we meet the needs of all our stakeholders – every day and everywhere.

  • Our Governance

    We are proud of our strong commitment to maintaining the highest standards of corporate governance.

  • Fueling Collaborative Innovation

    Nurturing a culture of innovation is critical to delivering on our mission to save and sustain lives. We partner with the healthcare community to continually find more efficient, smarter ways to help solve the world's most pressing healthcare challenges.

  • Corporate Responsibility

    We strive to create lasting value by empowering our patients, protecting our planet and championing our people and communities.

  • Inclusion & Diversity

    We are committed to attracting, motivating and retaining an inclusive and diverse workforce.

  • Our History

    For nearly a century, we’ve been focused on saving and sustaining lives and elevating patient care.

Patients

Helping you reach a healthy life, full of possibility.

Patients
  • General Healthcare

    Whether you are receiving care in the hospital, at your doctor’s office or at home, we are here to support every step of your journey.

  • Nutritional Care

    When medical conditions prevent you from adequately feeding yourself, we provide life-saving clinical nutrition options to help you regain your nutritional status.

  • Respiratory Care

    We are committed to helping you with innovative products that deliver effective, proven respiratory therapy in the hospital and at home.

Search Results

Baxter to Present at Barclays Global Healthcare Conference

Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Barclays Global Healthcare Conference on Thursday, March 17, 2022. Jay Saccaro, Baxter's chief financial officer, is scheduled to present at 8:00 a.m. Eastern Time.   The live webcast of Baxter's presentation can be accessed at www.baxter.com and will be available for replay through September 13, 2022. About Baxter 

Baxter Expands Cybersecurity Commitment, Joins Forces with U.S. Cybersecurity and Infrastructure Security Agency (CISA) Led Program

Baxter International Inc. (NYSE:BAX), a leading global medtech leader, announced that it has received authorization from the Common Vulnerability and Exposures (CVE®) program to be a CVE Numbering Authority. As a CVE Numbering Authority (CNA), Baxter is responsible for the assignment of CVE identifiers to cyber vulnerabilities for Baxter and Hillrom commercially available products, and for publicly disclosing information about the vulnerabilities in the associated CVE Record.

A Baxter employee sits at her home office

Providing Regulatory Guidance at BPS

Our Regulatory Affairs team at Baxter BioPharma Solutions navigates a diverse product portfolio and evolving challenges to bring new products to market, support contract manufacturing clients and advance our mission.

Baxter to Present at the Raymond James 43rd Annual Institutional Investors Conference

Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Raymond James 43rd Annual Institutional Investors Conference on Monday, March 7, 2022.  Jay Saccaro, Baxter's chief financial officer, is scheduled to present at 8:40 a.m. Eastern Time.    The live webcast of Baxter's presentation can be accessed at www.baxter.com and will be available for replay through March 6, 2023.

Baxter Issues Urgent Safety Communication to Reinforce Important Safety Information Regarding Upstream Occlusion Alarms for all Spectrum V8 and Spectrum IQ Infusion Pumps

Baxter International Inc. announced today it has issued an Urgent Safety Communication to reinforce important safety information regarding upstream occlusion alarms for all Spectrum V8 and Spectrum IQ infusion pumps. Incorrect administration set setup and/or incomplete resolution of upstream occlusion alarms may result in reduced delivery or non-delivery of medication, in some cases without alerting the user via pump alarm.

Baxter Reports Fourth-Quarter and Full-Year 2021 Results

Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the fourth quarter and full year ended Dec. 31, 2021, and provided its financial guidance for full-year and first-quarter 2022. Fourth-quarter and full-year 2021 results reflect 19 days of contribution from Hillrom Holdings, Inc. (Hillrom) subsequent to Baxter’s acquisition of the company on Dec. 13, 2021.

Baxter Declares Quarterly Dividend

Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.28 per share of common stock. The dividend is payable on April 1, 2022, to shareholders of record as of Feb. 25, 2022. The indicated annual dividend rate is $1.12 per share of common stock.  About Baxter

Baxter to Present at Citi's 2022 Virtual Healthcare Conference

Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at Citi's 2022 Virtual Healthcare Conference on Wednesday, February 23, 2022.  Jay Saccaro, Baxter's chief financial officer, is scheduled to present at 1:15 p.m. Eastern Time. The live webcast of Baxter's presentation can be accessed at www.baxter.com and will be available for replay through February 22, 2023. About Baxter 

Collage of Baxter employees on Baxter Brand

Baxter Proud

Celebrating 7 Years as a Best Place to Work for LGBTQ+ Equality

Collage of Baxter employees

Giving Back on our Day of Service

Baxter honors Dr. King's legacy through service to the community